Thursday, August 17, 2017 2:39:04 PM
Does this really surprise?
I'm not sure I've ever seen a more convoluted financing structure and agreement revelation ever from a publicly traded company.
The opacity is clearly mean't to confuse,cloak,and disorientate.
Combine this with the recently released Q2 results,and there's no logical justification for an investment in DECN.
Those that claim to find "justification" for an investment cannot offer one. So it's simply reduced to a "hunch" they have.
If you doubt the lack of evidence to support an investment in DECN,Friend's break down of the Q2 report was substantial and comprehensive.
Loan's examination of the recent financing exposes the unrevealed.
No Business that is run so poorly and is so financier friendly could survive unless it was a scam.
All investors pondering an investment in DECN...beware!!!!!!
Scoop
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM